Animal health company financial model, built free.
A three-statement Excel model for an animal health company, built from your own figures and checked to balance.
- Free account
- No card
- Usually ready within the hour
We use generative AI in parts of our process, so mistakes can occur. Every model should be checked by a person before it is relied on. Read more
Develops and sells medicines, vaccines, parasiticides and diagnostics for companion animals and livestock, through vets and distributors, with patent-protected franchises and species-driven demand.
In short
- 01
Three linked statements
Income statement, balance sheet and cash flow, linked in every period.
- 02
Valued two ways
Discounted cash flow and trading multiples, side by side.
- 03
Monthly to annual
Monthly, quarterly, half-yearly or annual periods, for up to 30 years.
- 04
Checked every period
A Checks sheet shows the balance sheet balances and the cash reconciles.
The sample, as Excel draws it.
Built by the same system and checks as yours, on illustrative figures: every sheet as Excel draws it, or live.

Illustrative figures: the sample describes no real business. The live preview shows values; your model’s Excel file has every formula.
How the model works for an animal health company.
- How it earns revenue3 formulasDevice sales and gross margin · All medical devicesDevice revenueUnits soldAverage selling priceDevice sales and gross margin · All medical devicesCost of goods soldDevice revenueGross marginDevice sales and gross margin · All medical devicesUnits soldAnnual unit run-rate at full accessMarket access (share of markets open)share of the year
- What drives its costs3 formulasOperating expenses · Across the businessTotal FTEsOperations and deliverySales and marketingTechnologyFinance, HR and administrationOperating expenses · Across the businessTotal average FTEsOperations and deliverySales and marketingTechnologyFinance, HR and administrationOperating expenses · Across the businessTotal staff costsSalariesOn-costsOther costs per FTE
- What it invests in3 formulasCorporate fixed assetsCapital expenditureRevenuefrom statementsCapex as % of revenueAdditional planned capexCorporate fixed assetsDepreciationDepreciation of the opening asset baseDepreciation of new capexCorporate fixed assetsClosing net book valueOpening net book valueCapital expenditureDepreciation
- How it is funded3 formulasDebtRepaymentsScheduled repaymentsPrepayments from an equity raise and the cash sweepDebtClosing balanceOpening balanceDrawdownsRepaymentsDebtInterest expenseOpening balanceAll-in interest rateshare of the year
- How profit becomes cash3 formulasWorking capitalTrade receivablesRevenuefrom statementsDebtor daysDays in periodWorking capitalInventoryDirect costs (positive)from statementsInventory daysDays in periodWorking capitalTrade payablesCash operating costs (positive)from statementsCreditor daysDays in period
22 parts, each one tested.
Every part is a tested building block with its own checks: yours is put together from the ones your business needs.
- Exchange rate (US dollar)Exchange rate by financial year
- Operating expensesHeadcount build by function
- Corporate costsFixed cost base indexed to CPI
- Working capitalFull working capital
- Income taxCorporate rate with tax losses
- Corporate fixed assetsStraight-line over remaining life
- DebtAmortising term loan
- Equity raisingDistribution reinvestment plan
- Dividends and distributionsPayout of net profit
- Discounted cash flow valuationDCF on free cash flow to the firm
- Multiples valuationEV / EBITDA multiple
- InventoryWeighted average cost
- Key-metric summaryLast-twelve-month and run-rate metrics
- Case selectionStackable stress toggles
- CPI forecastCPI glide path
- Device sales and gross marginUnits × average selling priceRevenue from devices, capital equipment, consumables and service, and the cost of goods sold.
- Clinical and regulatory pipelinePhase durations and benchmark probabilitiesPhase timing, regulatory milestones and the probability that each asset reaches market.
- Sales forecast and launch curveIn-market product trendIn-market net sales of each asset before loss of exclusivity and before risking.
- Loss of exclusivity (patent cliff)Erosion curve after expiryErosion of in-market sales after patents and regulatory exclusivity expire and generics or biosimilars enter.
- Commercialisation and deal economicsOwn sales with margin ratiosHow each asset's sales reach the company — own product sales with their costs, or upfront, milestone, royalty and profit-share income from partners.
- Clinical development costsCost per phaseResearch, clinical trial, manufacturing-development and regulatory costs for each asset, and any R&D tax incentive earned on them.
- Capacity and productionFeed × conversion yield
The numbers it tracks.
- 01revenue by species and franchise
- 02companion share
- 03price and volume growth
- 04gross margin
- 05R&D to sales
- 06EPS
What it is used for.
- Operating forecastGuide · Financial projections
- ValuationGuide · DCF valuation model
- Merger or acquisition (strategic)Guide · Financial modelling services
- Scenarios and sensitivities
More in pharma, biotech and medical devices.
- Pharmaceutical company financial model
- Clinical-stage biotech financial model
- Generic pharmaceutical company financial model
- Medical device company financial model
- Medical consumables manufacturer financial model
- Life science tools company financial model
- Plasma therapies company financial model
- Contract research organisation (CRO) financial model
- CDMO financial model
- Pharmaceutical royalty investor financial model
Looking for an animal health company financial model template? Ours arrives built for your business, with your figures in it.
Running a small business? Read what goes into a small business financial model.
See a finished model, sheet by sheetThe sample is built on illustrative figures and describes no real business. Models are calculations prepared from the information you provide. They are not financial advice and must be independently verified. See our terms.